Events

Summary: Maternal smoking is the leading cause of poor birth outcomes, increases the risk for adverse neonatal outcomes, and is associated with the development of chronic health conditions later in life. Additionally, maternal smoking during pregnancy involves a substantial economic toll. Although effective smoking cessation treatments for pregnant women are sparse, one exception to this is financial incentives-based interventions. This webinar will review the research, development, and outcomes produced by an innovative, remotely-delivered financial incentives intervention for reducing cigarette smoking during pregnancy. Participants will:

• Hear about Dr. Kurti’s research developing and implementing a smartphone-based financial incentives intervention for reducing smoking among pregnant women.
• Identify key components of financial incentives interventions, and how they can be delivered via smartphone.
• Learn how to obtain biochemical verification of abstinence in interventions for substance use that are delivered remotely.
• Learn how smartphone-based or other remotely-delivered interventions can expand treatment access to rural-dwelling or other historically under-served populations.

Presenter: Allison Kurti, PhD, Health Scientist, FDA Center for Tobacco Products

Register